SEARCH UNITED STATES ABOUT RESEARCH & DEVELOPMENT RESPONSIBILITY Home Page Celgene Corporate Responsibility Patients First PATIENTS FIRST December 13, 2018 Bold Science To Benefit Patients RelatedLinks Online Patient Resources Patients Patient Advocacy Sponsorship & Donation FAQ Celgene Risk Management REVLIMID REMS™ POMALYST REMS™ Underlying Celgene’s commitment to improve the lives of patients worldwide is our dedication to change the course of human health through bold pursuits in science and a promise to always put patients first. At Celgene, we believe that a commitment to medical progress must go hand-in-hand with a corresponding mission to help ensure that patients who can benefit from our discoveries have the opportunity to do so. Patient Safety, Support and Advocacy Celgene realizes its mission of improving the lives of patients around the world through our pioneering patient access programs, significant investment in clinical studies, support for continuing medical education and partnerships with charities that share our commitment to patients. Learn More Patient Support We embrace our responsibilities to patients today by helping ensure access to our medicines, and to patients tomorrow by ensuring that we can invest in future medical innovations that will help treat debilitating and chronic diseases. Learn More Font Size Responsibility Patients First Patient Safety, Support & Advocacy Research & Development Innovation Impact Awards Celgene Cooperation With European Patient Organizations EFPIA Spend Transparency Disclosure GLOBAL OFFICE LOCATIONS HAVE A QUESTION OR CONCERN? CONTACT US ABOUT RESEARCH & DEVELOPMENT RESPONSIBILITY INVESTORS SITE MAP PRIVACY POLICY LEGAL NOTICE COPYRIGHT © 2021 CELGENE CORPORATION A BRISTOL-MYERS SQUIBB COMPANY PRIVACY POLICY LEGAL NOTICE Celgene is a Bristol-Myers Squibb company Select CONTINUE for information about Celgene. Select BMS to learn more about Bristol Myers Squibb. CONTINUE BMS